Issue | Spring 2024 | Turning on the Bat Signal

Danielle Gerhard, PhD | Mar 15, 2024 | 10+ min read

From smart receptors to novel biologics, scientists plan to overcome the challenges of treating solid tumors.

Mariella Bodemeier Loayza Careaga, PhD | Mar 15, 2024 | 10+ min read

Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.

Hannah Thomasy, PhD | Mar 15, 2024 | 10+ min read

Scientists around the world investigate how bat immune systems cope with viral attacks and how this information could be used to keep humans safe.

Basic research successes offer glimpses into future scientific advancements, but the outcomes are subject to change.

After years in the lab, Danielle Gerhard put down the pipette and picked up the pen to follow her passion for storytelling.

Living drugs get a boost from emerging engineering strategies that focus on safety and specificity.

Cancer vaccines offer the opportunity to use the patient’s own immune system in the fight against tumors.

Researchers are using CRISPR for precise genetic manipulation of human-associated microbes as a promising avenue for improving human health.

Bats stay healthy while hosting some of the world’s deadliest viruses. Scientists are just beginning to understand how.

Vaccination has beaten back infections for more than a century. Now, it may be the next big step in battling cancer.

Genetic engineering pioneer Kevin Esvelt’s work highlights biotechnology’s immense potential for good—but also for catastrophe.

The road to developing monoclonal antibodies for effectively targeting cancer was paved with tenacity, passion, and strokes of luck.

Turning on the Bat Signal